Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Sep;78(3):729–735. doi: 10.1172/JCI112633

Demonstration of 26-hydroxylation of C27-steroids in human skin fibroblasts, and a deficiency of this activity in cerebrotendinous xanthomatosis.

S Skrede, I Björkhem, E A Kvittingen, M S Buchmann, S O Lie, C East, S Grundy
PMCID: PMC423662  PMID: 3745434

Abstract

26-Hydroxylation of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha-triol and other C27-steroids was demonstrated in cultured skin fibroblasts from healthy individuals. Activities in skin fibroblasts were approximately 5-10% of those previously found in human liver homogenates, and were inhibited by CO. The apparent Km was lowest for 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha-triol (1.3 mumol/liter) and highest for 5-cholestene-3 beta, 7 alpha-diol (12 mumol/liter). The rate of 26-hydroxylation was highest with 7 alpha-hydroxy-4-cholesten-3-one. These characteristics are similar to those of hepatic mitochondrial C27-steroid 26-hydroxylase. In skin fibroblasts from three patients with cerebrotendinous xanthomatosis (CTX), 26-hydroxylation of C27-steroids proceeded at a rate of only 0.2-2.5% of healthy controls. No accumulation of endogenous 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha-triol could be demonstrated in these cells, and the lowered formation of radioactive, 26-hydroxylated products could not be explained by dilution of the labeled exogenous substrate. The present results add strong evidence to the concept that the primary metabolic defect in CTX is a deficiency of C27-steroid 26-hydroxylase.

Full text

PDF
729

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atsuta Y., Okuda K. Partial purification and characterization of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha-triol and 5 beta-cholestane-3 alpha, 7 alpha-diol 27-monooxygenase. J Lipid Res. 1982 Feb;23(2):345–351. [PubMed] [Google Scholar]
  2. Björkhem I., Fausa O., Hopen G., Oftebro H., Pedersen J. I., Skrede S. Role of the 26-hydroxylase in the biosynthesis of bile acids in the normal state and in cerebrotendinous xanthomatosis. An in vivo study. J Clin Invest. 1983 Jan;71(1):142–148. doi: 10.1172/JCI110742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Björkhem I., Gustafsson J., Johansson G., Persson B. Biosynthesis of bile acids in man. Hydroxylation of the C27-steroid side chain. J Clin Invest. 1975 Mar;55(3):478–486. doi: 10.1172/JCI107954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Björkhem I., Holmberg I. Assay and properties of a mitochondrial 25-hydroxylase active on vitamine D3. J Biol Chem. 1978 Feb 10;253(3):842–849. [PubMed] [Google Scholar]
  5. Bloch C. A., Watkins J. B. Determination of conjugated bile acids in human bile and duodenal fluid by reverse-phase high-performance liquid chromatography. J Lipid Res. 1978 May;19(4):510–513. [PubMed] [Google Scholar]
  6. Ishikawa T. T., Brazier J. B., Stewart L. E., Fallat R. W., Glueck C. J. Direct quantitation of cholestanol in plasma by gas-liquid chromatography. J Lab Clin Med. 1976 Feb;87(2):345–353. [PubMed] [Google Scholar]
  7. Javitt N. B., Kok E., Burstein S., Cohen B., Kutscher J. 26-Hydroxycholesterol. Identification and quantitation in human serum. J Biol Chem. 1981 Dec 25;256(24):12644–12646. [PubMed] [Google Scholar]
  8. Javitt N. B., Kok E., Cohen B., Burstein S. Cerebrotendinous xanthomatosis: reduced serum 26-hydroxycholesterol. J Lipid Res. 1982 May;23(4):627–630. [PubMed] [Google Scholar]
  9. Kandutsch A. A., Chen H. W. Inhibition of cholesterol synthesis by oxygenated sterols. Lipids. 1978 Oct;13(10):704–707. doi: 10.1007/BF02533749. [DOI] [PubMed] [Google Scholar]
  10. Menkes J. H., Schimschock J. R., Swanson P. D. Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system. Arch Neurol. 1968 Jul;19(1):47–53. doi: 10.1001/archneur.1968.00480010065004. [DOI] [PubMed] [Google Scholar]
  11. Norum K. R., Bremer J. The localization of acyl coenzyme A-carnitine acyltransferases in rat liver cells. J Biol Chem. 1967 Feb 10;242(3):407–411. [PubMed] [Google Scholar]
  12. Oftebro H., Björkhem I., Skrede S., Schreiner A., Pederson J. I. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. J Clin Invest. 1980 Jun;65(6):1418–1430. doi: 10.1172/JCI109806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ramsey R. B., Nicholas H. J. Brain lipids. Adv Lipid Res. 1972;10:143–232. doi: 10.1016/b978-0-12-024910-7.50011-7. [DOI] [PubMed] [Google Scholar]
  14. Salen G. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism. Ann Intern Med. 1971 Dec;75(6):843–851. doi: 10.7326/0003-4819-75-6-843. [DOI] [PubMed] [Google Scholar]
  15. Salen G., Shefer S., Cheng F. W., Dayal B., Batta A. K., Tint G. S. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis. J Clin Invest. 1979 Jan;63(1):38–44. doi: 10.1172/JCI109275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Salen G., Shefer S., Setoguchi T., Mosbach E. H. Bile alcohol metabolism in man. Conversion of 5beta-cholestane-3alpha, 7alpha,12alpha, 25-tetrol to cholic acid. J Clin Invest. 1975 Jul;56(1):226–231. doi: 10.1172/JCI108071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Salen G., Shefer S., Tint G. S., Nicolau G., Dayal B., Batta A. K. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26. J Clin Invest. 1985 Aug;76(2):744–751. doi: 10.1172/JCI112030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Schreiner A., Hopen G., Skrede S. Cerebrotendinous xanthomatosis (cholestanolosis). Investigations on two sisters and their family. Acta Neurol Scand. 1975 May;51(5):405–416. [PubMed] [Google Scholar]
  19. Setoguchi T., Salen G., Tint G. S., Mosbach E. H. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain. J Clin Invest. 1974 May;53(5):1393–1401. doi: 10.1172/JCI107688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shefer S., Cheng F. W., Dayal B., Hauser S., Tint G. S., Salen G., Mosbach E. H. A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat. J Clin Invest. 1976 Apr;57(4):897–903. doi: 10.1172/JCI108366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Skrede S., Björkhem I., Buchmann M. S., Hopen G., Fausa O. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis. J Clin Invest. 1985 Feb;75(2):448–455. doi: 10.1172/JCI111719. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES